Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: Evolution of the sequential treatment approach
Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Roy B. Tishler(Dana-Farber Cancer Institute), Laura A. Goguen(Brigham and Women's Hospital), Charles M. Norris, Robert I. Haddad(Georgetown University), Anand Mahadevan(Geisinger Medical Center), Christopher A. Sullivan(Brigham and Women's Hospital), Lori J. Wirth(Massachusetts General Hospital)
Cited by 82
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926